Comparison of the Effectiveness of Once-Daily Alogliptin/Metformin and Twice-Daily Anagliptin/Metformin Combination Tablet in a Randomized, Parallel-Group, Open-Label Trial in Japanese Patients with Type 2 Diabetes

INTRODUCTION: The combination tablets of dipeptidyl peptidase-4 (DPP-4) inhibitors and metformin are used for both once-daily and twice-daily agents in Japan. If there is no difference in effectiveness between the once-daily and twice-daily DPP-4 inhibitor/metformin combination tablets, the once-dai...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamazaki, Shunsuke, Takano, Tatsuro, Tachibana, Koji, Takeda, Soichiro, Terauchi, Yasuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309109/
https://www.ncbi.nlm.nih.gov/pubmed/35793047
http://dx.doi.org/10.1007/s13300-022-01292-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309109/
https://www.ncbi.nlm.nih.gov/pubmed/35793047
http://dx.doi.org/10.1007/s13300-022-01292-2

Ejemplares similares